News Article
SPTS bestows Swansea Uni with £600k BluGlass shares
The semiconductor equipment maker is supporting the university's Department of Research and Innovation
SPTS Technologies UK has made a gift to research led Swansea University, of over £600,000 worth of shares in BluGlass Limited.
BluGlass is a green Australian public company established to commercialise innovative semiconductor technology. The company, which evolved out of Sydney's Macquarie University, has developed a novel semiconductor technology called remote plasma chemical vapour deposition (RPCVD), for the production of high efficiency devices such as LEDs and concentrated solar cells.
RPCVD has several potential advantages over current manufacturing techniques and through its low temperature deposition offers manufacturers higher performing devices and lower cost manufacturing. The company is currently developing GaN-on-silicon based LEDs.
BluGlass, last November, bought a Thomas Swan MOCVD reactor. The company is aiming to improve LED performance by growing low temperature RPCVD p-GaN on top of MOCVD grown multi-quantum wells. Growing the p-GaN layer at lower temperatures with RPCVD instead of MOCVD should reduce the InGaN MQW degradation, resulting in a brighter LED.
"SPTS has strong ties with Swansea University, and has benefited from the knowledge exchange projects through the University's Department of Research and Innovation (DRI)," states William Johnson, CEO at SPTS.
"The DRI which acts as the bridge between industry and academia has enabled us to extend the scope of our research beyond our existing markets and gain access to funding, which has proven invaluable to our R&D teams. This gift of shares in BluGlass is our way to pay back by 'paying it forward' to the University in not just the current value of the shares but the potential future value of BluGlass and the opportunities for potential collaboration between Swansea University, BluGlass and Sydney's Macquarie University."
Current collaboration with Swansea University includes a Technology Strategy Board (TSB) funded project for the development of micro-needles for bio-medical applications. The project which includes process equipment from SPTS for the University's clean room facility was instrumental in developing a design for manufacturing quality packaged micro-needles which are achieving a 100% success rate in initial testing.
"Swansea University are absolutely delighted by this gift and indeed with the highly successful and ongoing collaboration with SPTS and the University's College of Engineering, particularly the work being done with Dr Owen Guy, Associate Professor," comments Gerry Ronan, Head of IP at Swansea University. As a University we pride ourselves on our ability to collaborate with industry and this is an enlightened and most welcome way of strengthening such relationships."
Johnson added, "SPTS is at the forefront of micro-device process and manufacturing technology, and we remain committed to investing in R&D to ensure market competitiveness and industry sustainability. Our gift to Swansea University underpins our ongoing commitment to supporting the success of the Department of Research and Innovation, and we are proud to be able to support future generations of engineers and researchers at this world-class research-led institution."
BluGlass, which evolved out of Sydney's Macquarie University, has developed breakthrough semiconductor technology called remote plasma chemical vapour deposition (RPCVD), for the production of high efficiency devices such as light emitting diodes (LEDs) and concentrated solar cells. RPCVD has several potential advantages over current manufacturing techniques and through its low temperature deposition offers manufacturers higher performing devices and lower cost manufacturing.
BluGlass is a green Australian public company established to commercialise innovative semiconductor technology. The company, which evolved out of Sydney's Macquarie University, has developed a novel semiconductor technology called remote plasma chemical vapour deposition (RPCVD), for the production of high efficiency devices such as LEDs and concentrated solar cells.
RPCVD has several potential advantages over current manufacturing techniques and through its low temperature deposition offers manufacturers higher performing devices and lower cost manufacturing. The company is currently developing GaN-on-silicon based LEDs.
BluGlass, last November, bought a Thomas Swan MOCVD reactor. The company is aiming to improve LED performance by growing low temperature RPCVD p-GaN on top of MOCVD grown multi-quantum wells. Growing the p-GaN layer at lower temperatures with RPCVD instead of MOCVD should reduce the InGaN MQW degradation, resulting in a brighter LED.
"SPTS has strong ties with Swansea University, and has benefited from the knowledge exchange projects through the University's Department of Research and Innovation (DRI)," states William Johnson, CEO at SPTS.
"The DRI which acts as the bridge between industry and academia has enabled us to extend the scope of our research beyond our existing markets and gain access to funding, which has proven invaluable to our R&D teams. This gift of shares in BluGlass is our way to pay back by 'paying it forward' to the University in not just the current value of the shares but the potential future value of BluGlass and the opportunities for potential collaboration between Swansea University, BluGlass and Sydney's Macquarie University."
Current collaboration with Swansea University includes a Technology Strategy Board (TSB) funded project for the development of micro-needles for bio-medical applications. The project which includes process equipment from SPTS for the University's clean room facility was instrumental in developing a design for manufacturing quality packaged micro-needles which are achieving a 100% success rate in initial testing.
"Swansea University are absolutely delighted by this gift and indeed with the highly successful and ongoing collaboration with SPTS and the University's College of Engineering, particularly the work being done with Dr Owen Guy, Associate Professor," comments Gerry Ronan, Head of IP at Swansea University. As a University we pride ourselves on our ability to collaborate with industry and this is an enlightened and most welcome way of strengthening such relationships."
Johnson added, "SPTS is at the forefront of micro-device process and manufacturing technology, and we remain committed to investing in R&D to ensure market competitiveness and industry sustainability. Our gift to Swansea University underpins our ongoing commitment to supporting the success of the Department of Research and Innovation, and we are proud to be able to support future generations of engineers and researchers at this world-class research-led institution."
BluGlass, which evolved out of Sydney's Macquarie University, has developed breakthrough semiconductor technology called remote plasma chemical vapour deposition (RPCVD), for the production of high efficiency devices such as light emitting diodes (LEDs) and concentrated solar cells. RPCVD has several potential advantages over current manufacturing techniques and through its low temperature deposition offers manufacturers higher performing devices and lower cost manufacturing.
